Canada's bumper biotech budget

Article Abstract:

Canada's finance minister, Ralph Goodale, presented his federal budget for fiscal year 2005 on March 24, calling for record increases in government funds for the biotechnology sector particularly for research. According to MacDonald & Associates, a firm that maintains a database of venture capital and private equity activity in Canada, investment into life sciences by venture capitalists and foreign investors has declined steadily.

Canada, Research and Development in the Physical, Engineering, and Life Sciences, Science & research, Management dynamics, Life Sciences, Research, Management, Company business management, Goodale, Ralph E., MacDonald Associate Publishers

---

Angel investors shy away from biotech

Article Abstract:

The long and costly development times of biotech products as well as a tendency for venture capitalists (VCs) to set over diluting terms when entering in follow-on financing rounds are a few reasons why 'angel investors' are avoiding biotech startups. Unless angels return to a disciplined form of collaboration with VCs when investing in a seed-stage rounds there would always be an early-stage funding gap in the biotech sector.

Venture Capital Companies, Miscellaneous Intermediation, Investors, not elsewhere classified, Alliances, partnerships, Alliances and partnerships

---

Similar abstracts:

• Abstracts: Company cars cruising through Budget. Ringing the alarm on soaring car crime. Seeing green
• Abstracts: The number on biotech indexes. Putting biotech risk in its place. Going short on biotech
• Abstracts: Artificial cell-cell communication in yeast saccharomyces cerevisiae using signaling elements from Arabidopsis thaliana
• Abstracts: Nanospheres for DNA separation chips. Multiplexed detection of pathogen DNA with DNA-based fluorescence nanobarcodes

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.